Clinical Trial

Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)

Study acronym: SHIELD
Recruiting
View on ClinicalTrials.gov →
Summary
The Jacobs Institute is participating in a study designed to collect prospective clinical evidence to evaluate the approved use of the Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-20.
Status change: Active, Not Recruiting → Recruiting 2026-03-06
Trial Details
NCT Number NCT06793059
Lead Sponsor Jacobs institute
Conditions Aneurysm
Enrollment 10 participants
Start Date 2025-01-01
Primary Completion 2027-01-01 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-10